And finally, one last post, As I stated a few w
Post# of 148163
As I stated a few weeks ago, I believe our focus should be in the less crowded LH market. We have the chance to become SOC and first to market. M/m and S/C could be getting crowded soon. LH is ripe for the picking. Just need to make sure we obtain our endpoints and our trial design is flawless.